366 related articles for article (PubMed ID: 33962751)
41. The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy.
Asiry S; Kim G; Filippou PS; Sanchez LR; Entenberg D; Marks DK; Oktay MH; Karagiannis GS
Front Immunol; 2021; 12():654877. PubMed ID: 33927723
[TBL] [Abstract][Full Text] [Related]
42. MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasis.
Tsai TH; Gow CH; Liu YN; Tsai MF; Chang TH; Wu SG; Hsieh MS; Su KY; Shih JY
Cancer Med; 2023 Jul; 12(13):14511-14525. PubMed ID: 37212485
[TBL] [Abstract][Full Text] [Related]
43. Palladin regulation of the actin structures needed for cancer invasion.
Najm P; El-Sibai M
Cell Adh Migr; 2014; 8(1):29-35. PubMed ID: 24525547
[TBL] [Abstract][Full Text] [Related]
44. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.
Gulhati P; Bowen KA; Liu J; Stevens PD; Rychahou PG; Chen M; Lee EY; Weiss HL; O'Connor KL; Gao T; Evers BM
Cancer Res; 2011 May; 71(9):3246-56. PubMed ID: 21430067
[TBL] [Abstract][Full Text] [Related]
45. Fascin-1 in Cancer Cell Metastasis: Old Target-New Insights.
Sarantelli E; Mourkakis A; Zacharia LC; Stylianou A; Gkretsi V
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511011
[TBL] [Abstract][Full Text] [Related]
46. PKB/Akt-dependent regulation of cell motility.
Xue G; Hemmings BA
J Natl Cancer Inst; 2013 Mar; 105(6):393-404. PubMed ID: 23355761
[TBL] [Abstract][Full Text] [Related]
47. Cytoskeletal Actin Structure in Osteosarcoma Cells Determines Metastatic Phenotype via Regulating Cell Stiffness, Migration, and Transmigration.
Kita K; Asanuma K; Okamoto T; Kawamoto E; Nakamura K; Hagi T; Nakamura T; Shimaoka M; Sudo A
Curr Issues Mol Biol; 2021 Sep; 43(3):1255-1266. PubMed ID: 34698103
[TBL] [Abstract][Full Text] [Related]
48. Effects of raloxifene on breast cancer cell migration and invasion through the actin cytoskeleton.
Flamini MI; Fu XD; Sanchez AM; Giretti MS; Garibaldi S; Goglia L; Pisaneschi S; Tosi V; Genazzani AR; Simoncini T
J Cell Mol Med; 2009 Aug; 13(8B):2396-2407. PubMed ID: 18798864
[TBL] [Abstract][Full Text] [Related]
49. Rapid regulatory actions of sex steroids on cell movement through the actin cytoskeleton.
Giretti MS; Simoncini T
Steroids; 2008 Oct; 73(9-10):895-900. PubMed ID: 18308352
[TBL] [Abstract][Full Text] [Related]
50. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
Mierke CT
Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
[TBL] [Abstract][Full Text] [Related]
51. Arf proteins in cancer cell migration.
Casalou C; Faustino A; Barral DC
Small GTPases; 2016 Oct; 7(4):270-282. PubMed ID: 27589148
[TBL] [Abstract][Full Text] [Related]
52. Mitochondria-actin cytoskeleton crosstalk in cell migration.
Yadav T; Gau D; Roy P
J Cell Physiol; 2022 May; 237(5):2387-2403. PubMed ID: 35342955
[TBL] [Abstract][Full Text] [Related]
53. Small-molecule inhibitors of actin dynamics and cell motility.
Fenteany G; Zhu S
Curr Top Med Chem; 2003; 3(6):593-616. PubMed ID: 12570855
[TBL] [Abstract][Full Text] [Related]
54. CDC42EP5/BORG3 modulates SEPT9 to promote actomyosin function, migration, and invasion.
Farrugia AJ; Rodríguez J; Orgaz JL; Lucas M; Sanz-Moreno V; Calvo F
J Cell Biol; 2020 Sep; 219(9):. PubMed ID: 32798219
[TBL] [Abstract][Full Text] [Related]
55. Extracellular fluid viscosity enhances cell migration and cancer dissemination.
Bera K; Kiepas A; Godet I; Li Y; Mehta P; Ifemembi B; Paul CD; Sen A; Serra SA; Stoletov K; Tao J; Shatkin G; Lee SJ; Zhang Y; Boen A; Mistriotis P; Gilkes DM; Lewis JD; Fan CM; Feinberg AP; Valverde MA; Sun SX; Konstantopoulos K
Nature; 2022 Nov; 611(7935):365-373. PubMed ID: 36323783
[TBL] [Abstract][Full Text] [Related]
56. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
[TBL] [Abstract][Full Text] [Related]
57. Rab11-FIP3 is a Rab11-binding protein that regulates breast cancer cell motility by modulating the actin cytoskeleton.
Jing J; Tarbutton E; Wilson G; Prekeris R
Eur J Cell Biol; 2009 Jun; 88(6):325-41. PubMed ID: 19327867
[TBL] [Abstract][Full Text] [Related]
58. Actin cytoskeleton regulation of epithelial mesenchymal transition in metastatic cancer cells.
Shankar J; Nabi IR
PLoS One; 2015; 10(3):e0119954. PubMed ID: 25756282
[TBL] [Abstract][Full Text] [Related]
59. Tumor cells caught in the act of invading: their strategy for enhanced cell motility.
Wang W; Goswami S; Sahai E; Wyckoff JB; Segall JE; Condeelis JS
Trends Cell Biol; 2005 Mar; 15(3):138-45. PubMed ID: 15752977
[TBL] [Abstract][Full Text] [Related]
60. AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination.
Haffner MC; Esopi DM; Chaux A; Gürel M; Ghosh S; Vaghasia AM; Tsai H; Kim K; Castagna N; Lam H; Hicks J; Wyhs N; Biswal Shinohara D; Hurley PJ; Simons BW; Schaeffer EM; Lotan TL; Isaacs WB; Netto GJ; De Marzo AM; Nelson WG; An SS; Yegnasubramanian S
Nat Commun; 2017 Jul; 8(1):142. PubMed ID: 28747635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
